Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

April 13, 2026

Conditions
Esophageal NeoplasmsEndoscopic Mucosal ResectionHyaluronic Acid
Interventions
PROCEDURE

Submucous Endoscopic Dissection with hydroxyethylamide

The resection will be performed in three stages using hydroxyethylamide : delimitation, incision and dissection. Initially we will inject the hydroxyethylamide and examine the delimitation of the lesion. With Knife itself, using soft or Forced coagulation current, we will circumvent the limits of the lesion with punctual coagulations 5 mm away from it.

PROCEDURE

Submucous Endoscopic Dissection with Hyaluronic acid (TS-905 Blue Eye)

The resection will be performed in three stages using Hyaluronic acid (TS-905 Blue Eye) : delimitation, incision and dissection. Initially we will inject the Blue-Eyed and examine the delimitation of the lesion. With Knife itself, using soft or Forced coagulation current, we will circumvent the limits of the lesion with punctual coagulations 5 mm away from it.

Trial Locations (1)

01246-000

RECRUITING

Instituto do Câncer do Estado de São Paulo, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER